share_log

Virpax To Develop Intranasal Cannabidiol Product For Management Of Epilepsy In Adults And Children

Virpax To Develop Intranasal Cannabidiol Product For Management Of Epilepsy In Adults And Children

Virpax公司將開發用於成人和兒童癲癇治療的鼻用大麻二醇產品
Benzinga Real-time News ·  2021/09/20 09:03

Virpax To Develop Intranasal Cannabidiol Product For Management Of Epilepsy In Adults And Children

Virpax公司將開發用於成人和兒童癲癇治療的鼻用大麻二醇產品

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論